Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

Schizophrenia Research

Volumn 101, Issue 1-3, 2008, Pages 76-83

  Madeira, Caroline ^a   Freitas, Maria Eliza ^a   Vargas Lopes, Charles ^a   Wolosker, Herman ^b   Panizzutti, Rogério ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cerebral cortex; d amino acid oxidase (DAAO); d serine; NMDA receptors; Postmortem brain; Schizophrenia

Indexed keywords

CLOZAPINE; DEXTRO AMINO ACID OXIDASE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN CORTEX; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE DURATION; DRUG EXPOSURE; DRUG USE; ENZYME ACTIVITY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; ONSET AGE; PH; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; TISSUE PRESERVATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; D-AMINO-ACID OXIDASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 43049108742     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.02.002     Document Type: Article

References (42)

1. Arnold G., Liscum L., and Holtzman E. Ultrastructural localization of D-amino acid oxidase in microperoxisomes of the rat nervous system. J. Histochem. Cytochem. 27 (1979) 735-745
2. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry 7 (2002) 405-411
3. Bendikov I., Nadri C., Amar S., Panizzutti R., De Miranda J., Wolosker H., and Agam G. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr. Res. 90 (2007) 41-51
4. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., Rosa, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
6. De Miranda J., Santoro A., Engelender S., and Wolosker H. Human serine racemase: molecular cloning, genomic organization and functional analysis. Gene 256 (2000) 183-188
7. Detera-Wadleigh S.D., and McMahon F.J. G72/G30 in Schizophrenia and bipolar disorder: review and meta-analysis. Biol. Psychiatry (2006)
8. Foltyn V.N., Bendikov I., De Miranda J., Panizzutti R., Dumin E., Shleper M., Li P., Toney M.D., Kartvelishvily E., and Wolosker H. Serine racemase modulates intracellular D-serine levels through an alpha,beta-elimination activity. J. Biol. Chem. 280 (2005) 1754-1763
9. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158 (2001) 1367-1377
10. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., Coppola R., Egan M.F., and Weinberger D.R. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacol. 31 (2006) 2022-2032
11. Brazilian Aging Brain Study Group, Grinberg L.T., Ferretti R.E., Farfel J.M., Leite R., Pasqualucci C.A., Rosemberg S., Nitrini R., Saldiva P.H., and Jacob Filho W. Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains. Cell and Tissue Banking 8 (2007) 151-162
12. Gustafson E.C., Stevens E.R., Wolosker H., and Miller R.F. Endogenous D-serine contributes to NMDA receptor-mediated light-evoked responses in the vertebrate retina. J. Neurophysiol. 00057 (2007)
13. Hashimoto A., Nishikawa T., Konno R., Niwa A., Yasumura Y., Oka T., and Takahashi K. Free -serine, -aspartate and -alanine in central nervous system and serum in mutant mice lacking -amino acid oxidase. Neurosci. Lett. 152 (1993) 33-36
14. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29 (2005) 767-769
15. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S.i., Hasegawa H., Imai K., and Iyo M. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-Methyl-D-Aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 60 (2003) 572-576
16. Heresco-Levy U., Javitt D.C., Ebstein R., Vass A., Lichtenberg P., Bar G., Catinari S., and Ermilov M. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol. Psychiatry 57 (2005) 577-585
17. Horiike K., Tojo H., Arai R., Nozaki M., and Maeda T. D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res. 652 (1994) 297-303
18. Horiike K., Tojo H., Arai R., Yamano T., Nozaki M., and Maeda T. Localization of D-amino acid oxidase in Bergmann glial cells and astrocytes of rat cerebellum. Brain Res. Bull. 19 (1987) 587-596
19. Iwayama Y., Hashimoto K., Nakajima M., Toyota T., Yamada K., Shimizu E., Itokawa M., Hoshika A., Iyo M., and Yoshikawa T. Analysis of correlation between serum D-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes. Neurosci. Lett. 394 (2006) 101-104
20. Kartvelishvily E., Shleper M., Balan L., Dumin E., and Wolosker H. Neuron-derived D-serine release provides a novel means to activate N-Methyl- D-aspartate receptors. J. Biol. Chem. 281 (2006) 14151-14162
21. Katsuki H., Yoshida T., Tanegash. C., and Tanaka S. Improved direct method for determination of Keto Acids by 2,4-Dinitrophenylhydrazine. Anal. Biochem. 43 (1971) 349
22. Korostishevsky M., Kremer I., Kaganovich M., Cholostoy A., Murad I., Muhaheed M., Bannoura I., Rietschel M., Dobrusin M., Bening-Abu-Shach U., Belmaker R.H., Maier W., Ebstein R.P., and Navon. R. Transmission disequilibrium and haplotype analyses of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel. Am. J. Med. Genet. Part B Neuropsychiat. Genetics 141 (2006) 91-95
23. Korostishevsky M., Kaganovich M., Cholostoy A., Ashkenazi M., Ratner Y., Dahary D., Bernstein J., Bening-Abu-Shach U., Ben Asher E., and Lancet D. Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol. Psychiatry 56 (2004) 169-176
24. Moreno S., Nardacci R., Cimini A., and Maria P. Immunocytochemical localization of D-amino acid oxidase in rat brain. J. Neurocytol. 28 (1999) 169-185
25. Morita Y., Ujike H., Tanaka Y., Otani K., Kishimoto M., Morio A., Kotaka T., Okahisa Y., Matsushita M., Morikawa A., Hamase K., Zaitsu K., and Kuroda S. A genetic variant of the serine racemase gene is associated with schizophrenia. Biol. Psychiatry 61 (2007) 1200-1203
26. Mothet J.P., Parent A.T., Wolosker H., Brady Jr. R.O., Linden D.J., Ferris C.D., Rogawski M.A., and Snyder S.H. D-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4926-4931
27. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., and Oliet S.H.R. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125 (2006) 775-784
28. Panizzutti R., Rausch M., Zurbrugg S., Baumann D., Beckmann N., and Rudin M. The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain. Neurosci. Lett. 380 (2005) 111-115
29. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., Giegling I., Genius J., McCarley R.W., Moller H.J., and Grunze H. A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: Molecular, cellular, functional and behavioral abnormalities. Biol. Psychiatry 59 (2006) 721-729
30. Rutter A.R., Fradley R.L., Garrett E.M., Chapman K.L., Lawrence J.M., Rosahl T.W., and Patel S. Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating D-serine reuptake in the mouse CNS. Europ. J. Neurosci. 25 (2007) 1757-1766
31. Schell M.J., Molliver M.E., and Snyder S.H. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3948-3952
32. Schulze T.G., Ohlraun S., Czerski P.M., Schumacher J., Kassem L., Deschner M., Gross M., Tullius M., Heidmann V., Kovalenko S., Jamra R.A., Becker T., Leszczynska-Rodziewicz A., Hauser J., Illig T., Klopp N., Wellek S., Cichon S., Henn F.A., McMahon F.J., Maier W., Propping P., Nothen M.M., and Rietschel M. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: A first step toward a molecular genetic classification of psychiatric phenotypes. Am. J. Psychiatry 162 (2005) 2101-2108
33. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C.J., Tullius M., Kovalenko S., Bogaert A.V.D., Maier, et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9 (2004) 203-207
34. Shleper M., Kartvelishvily E., and Wolosker H. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J. Neurosci. 25 (2005) 9413-9417
35. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
36. Tsai G.C., Yang P.C., Chung L.C., Lange N., and Coyle J.T. D-serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 44 (1998) 1081-1089
37. Verrall L., Hutchinson L., Harrison P., and Burnet P. D-amino acid oxidase and serine racemase expression in the dorso-lateral pre-frontal cortex in schizophrenia. Int. J. Neuropsychopharmacol. 9 (2006) S143
38. Wang X., He G., Gu N., Yang J., Tang J., Chen Q., Liu X., Shen Y., Qian X., Lin W., Duan Y., Feng G., and He L. Association of G72/G30 with schizophrenia in the Chinese population. Biochem. Biophys. Res. Comm. 319 (2004) 1281-1286
39. Williams N.M., Green E.K., Macgregor S., Dwyer S., Norton N., Williams H., Raybould R., Grozeva D., Hamshere M., Zammit S., Jones L., Cardno A., Kirov G., Jones I., O'Donovan M.C., Owen M.J., and Craddock N. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 63 (2006) 366-373
40. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13409-13414
41. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., and Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels. Biol. Psychiatry 57 (2005) 1493-1503
42. Zou F., Li C., Duan S., Zheng Y., Gu N., Feng G., Xing Y., Shi J., and He L. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr. Res. 73 (2005) 257-261